Retraction
MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway
Paper Information
Record ID:
38695
Journal:
Publication Date:
January 09, 2020
Retraction Date:
August 25, 2022
(3.2 years years ago)
Subjects:
Institutions:
- Department of Ophthalmology and Optometry, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China
- Department of Cardiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637100, P.R. China
- Department of Ophthalmology, Yixing Eye Hospital, Yixing, Jiangsu 214200, P.R. China
- Department of Ophthalmology, Suining Central Hospital, Suining, Sichuan 637000, P.R. China
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/or.2022.8389Additional Notes:
see also: https://pubpeer.com/publications/57A364A6E70899DD9C1A1F9DF86A67
Citations (23)
23
Total Citations11
Post-Retraction(47.8%)
12
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
1
After 2+ years
1062
Days since retraction (latest)
Retraction Note: The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer
Fang Ma, Yangchun Xie, Yiyu Lei et al. (5 authors)
BMC Cancer
Open Access
Published: Jul 2025
1062 days after retraction
Knockdown of circ_0076305 decreases the paclitaxel resistance of non-small cell lung cancer cells by regulating TMPRSS4 via miR-936
Lin Su, Jiaxue Gou, C. Zhou et al. (7 authors)
Toxicology Research
Published: Jul 2024
1 citation
1 citation
676 days after retraction
HDAC9 and miR-512 Regulate CAGE-Promoted Anti-Cancer Drug Resistance and Cellular Proliferation
Minjeong Yeon, N S Kwon, Jaewhoon Jeoung et al. (4 authors)
Current Issues in Molecular Biology
Open Access
Published: May 2024
1 citation
1 citation
638 days after retraction
Retinoblastoma and Simulating Lesions
Myron Yanoff, Joseph W. Sassani
Elsevier eBooks
Published: Mar 2024
582 days after retraction
CircZCCHC2 (hsa_circ_0000854) promotes hepatocellular carcinoma progression through modulating miR-936/BTBD7 axis and activating Rho/ROCK2 pathway
Jun‐Jie Yin, Mian Wang, Jian Chen et al. (7 authors)
Non-coding RNA Research
Open Access
Published: Dec 2023
1 citation
1 citation
490 days after retraction
CircRNA Larp4b/miR-298-5p/Mef2c Regulates Cardiac Hypertrophy Induced by Angiotensin II
Qihai Xie, Xiangdong Xu, Danqun Xiong et al. (5 authors)
International Journal of Sports Medicine
Published: Nov 2023
445 days after retraction
Extracellular vesicles as a new horizon in the diagnosis and treatment of inflammatory eye diseases: A narrative review of the literature
Azam Habibi, Zeinab Zarei‐Behjani, Kimia Falamarzi et al. (12 authors)
Frontiers in Immunology
Open Access
Published: Mar 2023
9 citations
9 citations
196 days after retraction
Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases
Jingjing Wang, Shuyu Feng, Qian Zhang et al. (9 authors)
Molecular Neurobiology
Published: Jan 2023
13 citations
13 citations
141 days after retraction
Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression
Nasrin Ahangar Davoodi, Sajad Najafi, Zari Naderi Ghale-Noie et al. (12 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Dec 2022
25 citations
25 citations
120 days after retraction
Circ_0021573 acts as a competing endogenous RNA to promote the malignant phenotypes of human ovarian cancer cells
Lifang Liu, Han Bingkai, Lixia Liu et al. (8 authors)
Reproductive Biology
Published: Dec 2022
2 citations
2 citations
102 days after retraction
Circular RNA circDOCK1 contributes to osteosarcoma progression by acting as a ceRNA for miR-936 to regulate LEF1
Gang Xu, Haijiao Zhang, Yuxia Shi et al. (4 authors)
Journal of bone oncology
Open Access
Published: Sep 2022
4 citations
4 citations
15 days after retraction
The PI3K/AKT signaling pathway in cancer: Molecular mechanisms and possible therapeutic interventions
Mohammad Rafi Khezri, Reza Jafari, Keyvan Yousefi et al. (4 authors)
Experimental and Molecular Pathology
Published: May 2022
77 citations
77 citations
90 days before retraction
HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
Long Xu, Jian Wang, Buhan Liu et al. (9 authors)
Biomedicines
Open Access
Published: Feb 2022
11 citations
11 citations
203 days before retraction
Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer
Maryam Akbarzadeh, Ainaz Mihanfar, Shabnam Akbarzadeh et al. (5 authors)
Life Sciences
Published: Sep 2021
92 citations
92 citations
332 days before retraction
Downregulation of MIAT reduces the proliferation and migratory and invasive abilities of retinoblastoma cells by sponging miR‑665 and regulating LASP1
Xiabing Xu, Yadong Zhao, Gang Duan et al. (4 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Sep 2021
5 citations
5 citations
337 days before retraction
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer
Chun Yang, Stéphane Croteau, Pierre Hardy
Cellular Oncology
Open Access
Published: Jul 2021
42 citations
42 citations
394 days before retraction
Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9
Yuguang Zhu, Fengqin Hao
International Journal of Molecular Medicine
Open Access
Published: Mar 2021
10 citations
10 citations
540 days before retraction
Circ_0000527 Promotes Retinoblastoma Progression through Modulating miR-98-5p/XIAP Pathway
Binke Yu, Jifei Zhao, Yongxiao Dong
Current Eye Research
Published: Feb 2021
14 citations
14 citations
546 days before retraction
The emerging role of non-coding RNAs in the regulation of PI3K/AKT pathway in the carcinogenesis process
Soudeh Ghafouri‐Fard, Atefe Abak, Farhad Tondro Anamag et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2021
64 citations
64 citations
579 days before retraction
LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway
Lei Xu, Shenyu Zhu, Aidong Tang et al. (4 authors)
Inflammation Research
Published: Jan 2021
17 citations
17 citations
586 days before retraction
Exosomes derived from retinoblastoma cells enhance tumour deterioration by infiltrating the microenvironment
Shuilian Chen, Xi Chen, Jin Qiu et al. (14 authors)
Oncology Reports
Open Access
Published: Nov 2020
20 citations
20 citations
645 days before retraction
HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth
Keita Kanki, Ryota Watanabe, Le Nguyen Thai et al. (5 authors)
Cancers
Open Access
Published: Sep 2020
15 citations
15 citations
701 days before retraction
microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma
Qian Zheng, Qin Zhu, Cuiping Li et al. (8 authors)
Clinics
Open Access
Published: Jan 2020
13 citations
13 citations
967 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
3.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025